Abstract
Aurora kinases play pivotal role in mitosis. Aurora kinase A controls centrosome duplication, spindle pole integrity as well as bipolar spindle formation. Aurora kinase B is part of the chromosome passenger complex (CPC) and through its co-factors, drives chromosome congression, bidirectional tension on kinetochores and spindle checkpoint signaling, as well as cytokinesis completion. Both CPC and Aurora kinases are exclusively expressed during mitosis and are up regulated in many tumors. Their overexpression correlates with the level of genomic instability within tumors and these proteins are therefore proposed as potential targets for cancer therapy. This review describes the interplay between Aurora kinases in mitosis and the different strategies that have been developed towards their targeting.
Keywords: Aurora kinase, Survivin, Borealin, INCENP, passenger proteins, cancer therapy, mitosis, kinase inhibitors, Chromosome passenger complex, spindle
Current Enzyme Inhibition
Title: Aurora Kinases and Passenger Proteins as Targets for Cancer Therapy: An Update
Volume: 6 Issue: 1
Author(s): Hong-Lien VU, Thi My Nhung Hoang, Bertrand Favier and Annie Molla
Affiliation:
Keywords: Aurora kinase, Survivin, Borealin, INCENP, passenger proteins, cancer therapy, mitosis, kinase inhibitors, Chromosome passenger complex, spindle
Abstract: Aurora kinases play pivotal role in mitosis. Aurora kinase A controls centrosome duplication, spindle pole integrity as well as bipolar spindle formation. Aurora kinase B is part of the chromosome passenger complex (CPC) and through its co-factors, drives chromosome congression, bidirectional tension on kinetochores and spindle checkpoint signaling, as well as cytokinesis completion. Both CPC and Aurora kinases are exclusively expressed during mitosis and are up regulated in many tumors. Their overexpression correlates with the level of genomic instability within tumors and these proteins are therefore proposed as potential targets for cancer therapy. This review describes the interplay between Aurora kinases in mitosis and the different strategies that have been developed towards their targeting.
Export Options
About this article
Cite this article as:
VU Hong-Lien, Nhung Hoang My Thi, Favier Bertrand and Molla Annie, Aurora Kinases and Passenger Proteins as Targets for Cancer Therapy: An Update, Current Enzyme Inhibition 2010; 6 (1) . https://dx.doi.org/10.2174/157340810790712041
DOI https://dx.doi.org/10.2174/157340810790712041 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Meet Our Editorial Board Member
Current Cancer Drug Targets Energy Dependent Transport of Xenobiotics and Its Relevance to Multidrug Resistance
Current Cancer Drug Targets Treatment and Response to Statins: Gender-related Differences
Current Medicinal Chemistry Role of Metallothionein in Inflammatory Lung Diseases
Current Respiratory Medicine Reviews Sonic Hedgehog Pathway as a Target for Therapy in Angiogenesis-Related Diseases
Current Signal Transduction Therapy The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer
Current Medicinal Chemistry The Putative Use of Lithium in Alzheimer’s Disease
Current Alzheimer Research Nature Promises New Anticancer Agents: Interplay with the Apoptosis-related BCL2 Gene Family
Anti-Cancer Agents in Medicinal Chemistry Biology and Clinical Relevance of Mannose-Binding Lectin
Drug Design Reviews - Online (Discontinued) Virtual Screening of NCI Diversity Set II Lead to New Cyclin-Dependent Kinases 5 Inhibitors Using AutoDock
Letters in Drug Design & Discovery Molecular Targeting in Pancreatic Cancer
Reviews on Recent Clinical Trials Development of Arene Ruthenium Antitumor Complexes
Mini-Reviews in Medicinal Chemistry Neuroprotective Effects of Non-Classical Estrogen-Like Signaling Activators: from Mechanism to Potential Implications
CNS & Neurological Disorders - Drug Targets Novel Molecules Targeting Dyslipidemia and Atherosclerosis
Current Medicinal Chemistry Momordica charantia Seed and Aryl Extracts Potentiate Growth Inhibition and Apoptosis by Dual Blocking of PI3K/AKT and MAPK Pathways as a Downstream Target of EGFR Signaling in Breast Cancer Cells
Current Nutrition & Food Science Cyclopentenyl Cytosine (CPEC): An Overview of its in vitro and in vivo Activity
Current Cancer Drug Targets The Effect of Serotonin 5-HT2 Receptor Inhibitor on Vasomotor Responses
Vascular Disease Prevention (Discontinued) Acknowledgements to Reviewers
Recent Patents on Anti-Cancer Drug Discovery Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors
Current Pharmacogenomics and Personalized Medicine Smart Delivery and Controlled Drug Release with Gold Nanoparticles: New Frontiers in Nanomedicine
Recent Patents on Nanomedicine